The flip-flop HuR: Part of the problem or the solution in fighting cancer?

Journal of Clinical Investigation

Volumn 122, Issue 1, 2012, Pages 16-19

  Shultz, Jacqueline C ^a   Chalfant, Charles E ^a,b,c  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUR PROTEIN; MESSENGER RNA;

CELL POPULATION; COLITIS; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; IN VIVO STUDY; NEOPLASM; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA STABILITY;

ANIMALS; COLITIS; COLORECTAL NEOPLASMS; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; MYELOID CELLS;

EID: 84855431997     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI61677     Document Type: Note

References (23)

1. Keibel A, Singh V, Sharma MC. Inflammation, microenvironment, and the immune system in cancer progression. Curr Pharm Des. 2009; 15(17):1949-1955.
2. Yiakouvaki A, Dimitriou M, Karakasiliotis I, Eftychi C, Theocharis S, Kontoyiannis DL. Myeloid cell expression of the RNA-binding protein HuR protects mice from pathologic inflammation and colorectal carcinogenesis. J Clin Invest. 2012; 122(1):48-61.
3. Abdelmohsen K, Lal A, Kim HH, Gorospe M. Posttranscriptional orchestration of an anti-apoptotic program by HuR. Cell Cycle. 2007;6(11):1288-1292. (Pubitemid 47327958)
4. Brennan CM, Steitz JA. HuR and mRNA stability. Cell Mol Life Sci. 2001;58(2):266-277. (Pubitemid 32217358)
5. Gorospe M. HuR in the mammalian genotoxic response: post-transcriptional multitasking. Cell Cycle. 2003;2(5):412-414.
6. Katsanou V, et al. HuR as a negative posttranscriptional modulator in inflammation. Mol Cell. 2005; 19(6):777-789. (Pubitemid 41316672)
7. Hostetter C, et al. Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells. Cancer Biol Ther. 2008;7(9):1496-1506.
8. Hinman MN, Lou H. Diverse molecular functions of Hu proteins. Cell Mol Life Sci. 2008; 65(20):3168-3181.
9. Mazan-Mamczarz K, et al. RNA-binding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci U S A. 2003; 100(14):8354-8359. (Pubitemid 36842549)
10. Zou T, et al. Polyamine depletion increases cytoplasmic levels of RNA-binding protein HuR leading to stabilization of nucleophosmin and p53 mRNAs. J Biol Chem. 2006;281(28):19387-19394. (Pubitemid 44035444)
11. Tong X, Pelling JC. Enhancement of p53 expression in keratinocytes by the bioflavonoid apigenin is associated with RNA-binding protein HuR. Mol Carcinog. 2009;48(2):118-129.
12. Lopez de Silanes I, Fan J, Galban CJ, Spencer RG, Becker KG, Gorospe M. Global analysis of HuR regulated gene expression in colon cancer systems of reducing complexity. Gene Expr. 2004;12(1):49-59. (Pubitemid 39238136)
13. Lopez de Silanes I, et al. Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene. 2003;22(46):7146-7154.
14. Lopez de Silanes I, Lal A, Gorospe M. HuR: posttranscriptional paths to malignancy. RNA Biol. 2005;2(1):11-13.
15. Rhee WJ, Ni CW, Zheng Z, Chang K, Jo H, Bao G. HuR regulates the expression of stress-sensitive genes and mediates inflammatory response in human umbilical vein endothelial cells. Proc Natl Acad Sci U S A. 2010;107(15):6858-6863.
16. Yoo PS, et al. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival. Ann Surg Oncol. 2009;16(1):200-207.
17. Denkert C, et al. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin Cancer Res. 2004;10(16):5580-5586. (Pubitemid 39100499)
18. Denkert C, et al. Overexpression of the embryoniclethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res. 2004;64(1):189-195. (Pubitemid 38114097)
19. Gubin MM, et al. Overexpression of the RNA binding protein HuR impairs tumor growth in triple negative breast cancer associated with deficient angiogenesis. Cell Cycle. 2010;9(16):3337-3346.
20. Costantino CL, et al. The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase. Cancer Res. 2009;69(11):4567-4572.
21. Atreya I, Neurath MF. Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies. Expert Rev Anticancer Ther. 2008;8(4):561-572. (Pubitemid 351818351)
22. Lim SJ, Lee SH, Joo SH, Song JY, Choi SI. Cytoplasmic expression of HuR is related to cyclooxygenase-2 expression in colon cancer. Cancer Res Treat. 2009;41(2):87-92.
23. Young LE, Sanduja S, Bemis-Standoli K, Pena EA, Price RL, Dixon DA. The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis. Gastroenterology. 2009;136(5):1669-1679.